drugset / Trial / NCT02688790
Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to evaluate the Pharmacokinetic (PK) profile of a single intravenous (IV) infusion dose of dalbavancin, and to evaluate the safety and tolerability of a single dalbavancin IV infusion.
Timeline
- Start
- 2016-04-01
- Primary completion
- 2019-04-03
- Completion
- 2019-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dalbavancin | Other / unclassified | 22.5 mg/kg | Intravenous |